ArticleFrontiers in endocrinology2026
Association of hyperuricemia and a three-component lifestyle score with elevated cardiometabolic risk: a health-examination-based cross-sectional study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hyperuricemia (HUA) is increasingly recognized as being associated with cardiometabolic abnormalities, but its relationszhip with available lifestyle indicators in health-examination populations remains uncertain. This health-examination-based cross-sectional study examined whether hyperuricemia is associated with elevated cardiometabolic risk and whether the available three-component lifestyle score modifies this association. Methods: A health-examination-based cross-sectional study was conducted among 24,795 adult residents who attended the Xindian Town Health Center in Fuzhou, China. Participants underwent physical examinations, laboratory testing, and face-to-face questionnaire interviews. Hyperuricemia was defined as serum uric acid >420 umol/L in men and postmenopausal women or >360 umol/L in premenopausal women. Elevated cardiometabolic risk was defined as the presence of at least three of the following components: elevated blood pressure, abdominal obesity, abnormal glucose metabolism, elevated triglycerides, or reduced HDL-C. The TLS (0-3 points) comprised non-current smoking, non-excessive alcohol use, and adequate physical activity; dietary intake was not available and was therefore not included. Logistic regression and interaction analyses were adjusted for age and sex. Because the outcome was common, odds ratios were interpreted as odds rather than risk ratios. Results: The prevalence of non-current smoking, non-excessive alcohol use, and adequate physical activity was 90.9%, 95.6%, and 63.2%, respectively. The numbers of participants with TLS <=1, 2, and 3 were 1,322, 9,593, and 13,880, respectively. After adjustment for age and sex, a TLS of 2 or 3 was not significantly associated with overall elevated cardiometabolic risk compared with TLS <=1. Hyperuricemia was associated with higher odds of elevated cardiometabolic risk (OR = 1.66, 95%CI: 1.53-1.79). The multiplicative interaction between HUA and TLS was not statistically significant (OR = 0.96, 95%CI: 0.85-1.08, P = 0.462). No statistically significant additive interaction was detected (RERI = 0.15, 95%CI: -0.10 to 0.38; AP = 0.09, 95%CI: -0.06 to 0.22; SI = 1.30, 95%CI: 0.84 to 2.16). Conclusion: Hyperuricemia was associated with elevated cardiometabolic risk in this health-examination-based cross-sectional population. The available three-component lifestyle score did not show a statistically significant association with overall elevated cardiometabolic risk or robust interaction with HUA after age- and sex-adjustment. Because diet, socioeconomic factors, renal function, and specific urate-lowering therapy data were unavailable, these findings should be interpreted as hypothesis-generating associations rather than causal effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.